Saksa J - Search Results

1

Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.

Coric V, Taskiran S, Pittenger C, Wasylink S, Mathalon DH, Valentine G, Saksa J, Wu YT, Gueorguieva R, Sanacora G, Malison RT, Krystal JH. Coric V, et al. Among authors: saksa j. Biol Psychiatry. 2005 Sep 1;58(5):424-8. doi: 10.1016/j.biopsych.2005.04.043. Biol Psychiatry. 2005. PMID: 15993857 Clinical Trial.

2

Resting state functional connectivity predicts neurofeedback response.

Scheinost D, Stoica T, Wasylink S, Gruner P, Saksa J, Pittenger C, Hampson M. Scheinost D, et al. Among authors: saksa j. Front Behav Neurosci. 2014 Sep 24;8:338. doi: 10.3389/fnbeh.2014.00338. eCollection 2014. Front Behav Neurosci. 2014. PMID: 25309375 Free PMC article.

3

Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.

Woods SW, Morgenstern H, Saksa JR, Walsh BC, Sullivan MC, Money R, Hawkins KA, Gueorguieva RV, Glazer WM. Woods SW, et al. Among authors: saksa jr. J Clin Psychiatry. 2010 Apr;71(4):463-74. doi: 10.4088/JCP.07m03890yel. Epub 2010 Feb 9. J Clin Psychiatry. 2010. PMID: 20156410 Free PMC article.

4

Real-time fMRI biofeedback targeting the orbitofrontal cortex for contamination anxiety.

Hampson M, Stoica T, Saksa J, Scheinost D, Qiu M, Bhawnani J, Pittenger C, Papademetris X, Constable T. Hampson M, et al. Among authors: saksa j. J Vis Exp. 2012 Jan 20;(59):3535. doi: 10.3791/3535. J Vis Exp. 2012. PMID: 22297729 Free PMC article.

5

Orbitofrontal cortex neurofeedback produces lasting changes in contamination anxiety and resting-state connectivity.

Scheinost D, Stoica T, Saksa J, Papademetris X, Constable RT, Pittenger C, Hampson M. Scheinost D, et al. Among authors: saksa j. Transl Psychiatry. 2013 Apr 30;3(4):e250. doi: 10.1038/tp.2013.24. Transl Psychiatry. 2013. PMID: 23632454 Free PMC article.

6

Glycine treatment of the risk syndrome for psychosis: report of two pilot studies.

Woods SW, Walsh BC, Hawkins KA, Miller TJ, Saksa JR, D'Souza DC, Pearlson GD, Javitt DC, McGlashan TH, Krystal JH. Woods SW, et al. Among authors: saksa jr. Eur Neuropsychopharmacol. 2013 Aug;23(8):931-40. doi: 10.1016/j.euroneuro.2012.09.008. Epub 2012 Oct 22. Eur Neuropsychopharmacol. 2013. PMID: 23089076 Free PMC article. Clinical Trial.

7

Effects of levetiracetam on tardive dyskinesia: a randomized, double-blind, placebo-controlled study.

Woods SW, Saksa JR, Baker CB, Cohen SJ, Tek C. Woods SW, et al. Among authors: saksa jr. J Clin Psychiatry. 2008 Apr;69(4):546-54. doi: 10.4088/jcp.v69n0405. J Clin Psychiatry. 2008. PMID: 18312060 Clinical Trial.

8

Mood-stabilizer-maintained, remitted bipolar patients: taper and discontinuation of adjunctive antipsychotic medication.

Saksa JR, Baker CB, Woods SW. Saksa JR, et al. Gen Hosp Psychiatry. 2004 May-Jun;26(3):233-6. doi: 10.1016/j.genhosppsych.2004.02.002. Gen Hosp Psychiatry. 2004. PMID: 15121352 Clinical Trial.

9

Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy.

Aaronson CJ, Shear MK, Goetz RR, Allen LB, Barlow DH, White KS, Ray S, Money R, Saksa JR, Woods SW, Gorman JM. Aaronson CJ, et al. Among authors: saksa jr. J Clin Psychiatry. 2008 Mar;69(3):418-24. doi: 10.4088/jcp.v69n0312. J Clin Psychiatry. 2008. PMID: 18278989

10

Cognitive behavior therapy for early psychosis: a comprehensive review of individual vs. group treatment studies.

Saksa JR, Cohen SJ, Srihari VH, Woods SW. Saksa JR, et al. Int J Group Psychother. 2009 Jul;59(3):357-83. doi: 10.1521/ijgp.2009.59.3.357. Int J Group Psychother. 2009. PMID: 19548785 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters